Organization
Yunhe Pharmaceutical (Tianjin)
1 clinical trial
Clinical trial
A Phase I/IIa Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate CancerStatus: Recruiting, Estimated PCD: 2025-03-31